Market Cap (In CNY)
7.77 Billion
Revenue (In CNY)
8.16 Billion
Net Income (In CNY)
358.45 Million
Avg. Volume
38.08 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.72-6.69
- PE
- 21.83
- EPS
- 0.24
- Beta Value
- 0.287
- ISIN
- CNE0000009G0
- CUSIP
- -
- CIK
- -
- Shares
- 1458274518.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Zhou Kai
- Employee Count
- -
- Website
- https://www.nepharm.com
- Ipo Date
- 1996-05-23
- Details
- Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products; API products comprising fosfomycin, anti-aids, and other products; and chemical products, including chemical and pharmaceutical intermediates, chiral separation reagent products, etc. The company also provides digestives, narcotic medicines, cardiovascular, cerebrovascular medicines, etc. In addition, it engages in medical distribution business. Northeast Pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Shenyang, China.
More Stocks
-
3147
-
M3M
-
ESLTElbit Systems Ltd.
ESLT
-
0R0UCoeur Mining, Inc.
0R0U
-
RNR
-
BYFC
-
BPCL
-
FHN-PFFirst Horizon Corporation
FHN-PF